Articles Archives
10/30/2025
Cryoport Systems Sets New Benchmark for the Global Regenerative Medicine Supply Chain
Cryoport Systems has achieved a significant milestone by becoming the first global supply chain company worldwide to secure ISO 21973:2020 certification from the DNV Business Assurance. This certification marks a pivotal advancement in our mission to set the highest benchmarks for safety, traceability, and product integrity in the cell and gene therapy sector and across the life sciences.
10/29/2025
Cryoport Systems Wins CPHI Pharma Award for Supply Chain Excellence
We are proud to announce that Cryoport Systems has been awarded the prestigious Supply Chain Excellence Award at the 2025 CPHI Pharma Awards, a recognition that celebrates innovation, impact, and leadership in pharmaceutical supply chain management. This honor reflects our unwavering commitment to transforming the way life-saving therapies are managed and delivered to patients across the globe.
10/01/2025
Cryoport Systems Redefines the Global Supply Chain with Launch of New Facility Near Paris, France
Cryoport Systems is thrilled to announce the grand opening of our revolutionary Global Supply Chain Center in Louvre, France. This cutting-edge campus is a one-stop location for end-to-end, temperature-controlled supply chain solutions and is designed to tackle the most complex challenges in the life sciences industry.
09/13/2025
Cryoport Systems Wins Best Cell & Gene Therapy Supplier Award at APCGTEA 2025
Cryoport Systems is proud to announce that we have been awarded Best Cell & Gene Therapy Supplier – Cell Processing Systems at the 2025 Asia-Pacific Cell & Gene Therapy Excellence Awards (APCGTEA).
07/29/2025
A Glimpse Inside the Future of ATMP Supply Chains: Alison Pritchard on the Beyond Biotech Podcast
In an industry where innovation moves fast but patient access often lags behind, how can we build supply chains that are not only compliant and efficient, but also flexible and ready to scale? That’s the question Alison Pritchard, Vice President of Business Development for Cryoport Systems, tackles in her recent interview with Beyond Biotech, the podcast from Labiotech.eu. Alison explores the state of the advanced therapy medicinal products (ATMP) market in 2025 and what it will take to meet the rising expectations of therapeutic developers, regulators, and – most importantly – patients.
06/23/2025
New in Contract Pharma: Enabling the Outcome Through End-to-End Supply Chain Excellence
Cryoport Systems is featured in Contract Pharma with an article discussing the benefits of a unified, end-to-end supply chain platform for advanced therapies. Titled "Enabling the Outcome: The Power of an End-to-End Supply Chain Platform for Advanced Therapies," the piece highlights the growing demand from advanced therapy sponsors, CDMOs, and clinical partners for integrated solutions that encompass logistics, BioServices, biostorage, and consulting in one partnership.
06/09/2025
Cryoport Systems Nominated for Three APCGTEA Awards
Cryoport Systems has been officially nominated for three prestigious categories in the 2025 Asia-Pacific Cell & Gene Therapy Excellence Awards (APCGTEA). These nominations highlight the strength of our innovation, commitment to quality, and enduring partnership with the advanced therapies community across the region.
05/19/2025
Addressing the EMEA Cold Chain Challenge for Cell and Gene Therapies: Cryoport Systems Featured in Labiotech.eu
In a recent Labiotech.eu article, Florent Belon, Managing Director for Cryoport Systems in France, discusses how regulatory diversity, infrastructure gaps, and extreme climate variation across EMEA intensify the need for customized, compliant cold chain solutions.
05/01/2025
